Packing, specificity, and mutability at the binding interface between the p160 coactivator and CREB‐binding protein

Among the most common interaction motifs between nuclear proteins is the recognition of one or more amphipathic helices. In an effort to determine principles behind this recognition, we have investigated the interaction between the p160 coactivator protein ACTR and the ACTR‐binding domain of the CREB‐binding protein, CBP. The two proteins use relatively small portions of their primary sequences to form a single synergistically folded domain consisting of six intertwined α‐helices, three from each protein. Neither of the component polypeptides forms a cooperatively folded domain in isolation. However, a considerable amount of residual secondary structure remains in the isolated CBP domain according to CD spectroscopy. Chemical denaturation, differential scanning calorimetry, and ANS binding experiments demonstrate that the isolated CBP domain is not entirely unfolded but forms a helical state with the characteristics of a molten globule. Mutations probing the functional and energetic significance of a buried intermolecular Arg–Asp salt bridge in the interface of the protein complex suggest that these residues are tuned for functional discrimination and not strictly for binding affinity or stability. These results suggest a mechanism for formation of the complex where the unfolded ACTR domain interacts with the partly folded CBP domain in a rapid and specific manner to form the final stable complex.

[1]  R. Evans,et al.  Mechanism of corepressor binding and release from nuclear hormone receptors. , 1999, Genes & development.

[2]  Kam Y. J. Zhang,et al.  Conversion of monomeric protein L to an obligate dimer by computational protein design , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  H. Sheppard,et al.  Analysis of the Steroid Receptor Coactivator 1 (SRC1)-CREB Binding Protein Interaction Interface and Its Importance for the Function of SRC1 , 2001, Molecular and Cellular Biology.

[4]  P. Evans,et al.  The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase Gcn5p , 2000, The EMBO journal.

[5]  P. Privalov,et al.  Intermediate states in protein folding. , 1996, Journal of molecular biology.

[6]  R. Goodman,et al.  CBP/p300 in cell growth, transformation, and development. , 2000, Genes & development.

[7]  Á. Pascual,et al.  Nuclear hormone receptors and gene expression. , 2001, Physiological reviews.

[8]  J. Chen,et al.  The SRC family of nuclear receptor coactivators. , 2000, Gene.

[9]  G. Crabtree,et al.  Structural basis of dimerization, coactivator recognition and MODY3 mutations in HNF-1α , 2000, Nature Structural Biology.

[10]  P. Privalov,et al.  Stability of protein structure and hydrophobic interaction. , 1988, Advances in protein chemistry.

[11]  C. Pace Determination and analysis of urea and guanidine hydrochloride denaturation curves. , 1986, Methods in enzymology.

[12]  K. Kuwajima,et al.  The molten globule state as a clue for understanding the folding and cooperativity of globular‐protein structure , 1989, Proteins.

[13]  Peter E Wright,et al.  Solution Structure of the KIX Domain of CBP Bound to the Transactivation Domain of CREB: A Model for Activator:Coactivator Interactions , 1997, Cell.

[14]  H. Gronemeyer,et al.  The coactivator TIF2 contains three nuclear receptor‐binding motifs and mediates transactivation through CBP binding‐dependent and ‐independent pathways , 1998, The EMBO journal.

[15]  R. Evans,et al.  Coexpression of nuclear receptor partners increases their solubility and biological activities. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Millard H. Lambert,et al.  Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα , 2002, Nature.

[17]  K. Bailey Proteins, Amino-Acids and Peptides as Ions and Dipolar Ions , 1945, Nature.

[18]  E. Fraenkel,et al.  A small domain of CBP/p300 binds diverse proteins: solution structure and functional studies. , 2001, Molecular cell.

[19]  David A. Agard,et al.  The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.

[20]  S. Tenbaum,et al.  Nuclear receptors: structure, function and involvement in disease. , 1997, The international journal of biochemistry & cell biology.

[21]  C. Glass,et al.  The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.

[22]  R. Tjian,et al.  Transcriptional coactivator complexes. , 2001, Annual review of biochemistry.

[23]  P. Privalov,et al.  Thermodynamic puzzle of apomyoglobin unfolding. , 1994, Journal of molecular biology.

[24]  Wei Xu,et al.  Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators , 2002, Nature.

[25]  S. Burley X-ray crystallographic studies of eukaryotic transcription factors. , 1998, Cold Spring Harbor Symposia on Quantitative Biology.

[26]  Miguel Beato,et al.  Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.

[27]  Rachel E. Klevit,et al.  Structure of a BRCA1–BARD1 heterodimeric RING–RING complex , 2001, Nature Structural Biology.

[28]  R. Sauer,et al.  Transcription factors: structural families and principles of DNA recognition. , 1992, Annual review of biochemistry.

[29]  R. L. Baldwin,et al.  Comparison of NH exchange and circular dichroism as techniques for measuring the parameters of the helix-coil transition in peptides. , 1997, Biochemistry.

[30]  T. Alber Structure of the leucine zipper , 1992, Current Biology.

[31]  R. Evans,et al.  Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 , 1997, Cell.

[32]  T. Willson,et al.  Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ , 1998, Nature.

[33]  N. Pavletich,et al.  Structure of the p53 Tumor Suppressor Bound to the Ankyrin and SH3 Domains of 53BP2 , 1996, Science.